Tirgan BioPharmaceuticals is the first and only biotech company that is committed to bringing innovative and effective therapies to patients with keloid disorder.

Based in New York City and currently housed at Harlem BioSpace, Tirgan is focusing on research and development of better treatments for keloid disorder.

Resource Corner

Resource Corner is designed to enable patients and others concerned to gain access to quality information.

Latest News

04 Jan 2013 | 5:30 am

Tirgan BioPharmaceuticals was invited to join Harlem Biospace.

04 Jan 2013 | 5:30 am